Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five brokerages that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $243.3333.
NUTX has been the topic of a number of research analyst reports. Lake Street Capital assumed coverage on shares of Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target on the stock. B. Riley Financial started coverage on shares of Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 target price on the stock. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Finally, Zacks Research raised Nutex Health to a “hold” rating in a research note on Monday, June 29th.
View Our Latest Report on Nutex Health
Nutex Health Trading Down 2.9%
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating the consensus estimate of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The company had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. On average, equities analysts forecast that Nutex Health will post 22.72 EPS for the current year.
Hedge Funds Weigh In On Nutex Health
Several institutional investors have recently made changes to their positions in the company. Bank of America Corp DE raised its holdings in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after purchasing an additional 2,748 shares during the period. Jane Street Group LLC bought a new position in shares of Nutex Health during the first quarter valued at approximately $522,000. JPMorgan Chase & Co. boosted its stake in shares of Nutex Health by 41,430.0% during the second quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock valued at $1,034,000 after purchasing an additional 8,286 shares in the last quarter. Finally, Legal & General Group Plc purchased a new position in Nutex Health during the second quarter valued at approximately $454,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.
Nutex Health Company Profile
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Articles
- Five stocks we like better than Nutex Health
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
